Show simple item record

dc.contributor.authorCantor, Sharon B.
dc.contributor.authorDrapkin, Ronny
dc.contributor.authorZhang, Fan
dc.contributor.authorLin, Yafang
dc.contributor.authorHan, Juliana
dc.contributor.authorPamidi, Sushmita
dc.contributor.authorLivingston, David M.
dc.date2022-08-11T08:08:02.000
dc.date.accessioned2022-08-23T15:40:00Z
dc.date.available2022-08-23T15:40:00Z
dc.date.issued2004-02-26
dc.date.submitted2008-12-10
dc.identifier.citation<p>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2357-62.</p>
dc.identifier.issn0027-8424 (Print)
dc.identifier.doi10.1073/pnas.0308717101
dc.identifier.pmid14983014
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26306
dc.description.abstractBACH1 is a nuclear protein that directly interacts with the highly conserved, C-terminal BRCT repeats of the tumor suppressor, BRCA1. Mutations within the BRCT repeats disrupt the interaction between BRCA1 and BACH1, lead to defects in DNA repair, and result in breast and ovarian cancer. BACH1 is necessary for efficient double-strand break repair in a manner that depends on its association with BRCA1. Moreover, some women with early-onset breast cancer and no abnormalities in either BRCA1 or BRCA2 carry germline BACH1 coding sequence changes, suggesting that abnormal BACH1 function contributes to tumor induction. Here, we show that BACH1 is both a DNA-dependent ATPase and a 5'-to-3' DNA helicase. In two patients with early-onset breast cancer who carry distinct germline BACH1 coding sequence changes, the resulting proteins are defective in helicase activity, indicating that these sequence changes disrupt protein function. These results reinforce the notion that mutant BACH1 participates in breast cancer development.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=14983014&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC356955
dc.subjectAdenosine Triphosphatases
dc.subjectAmino Acid Substitution
dc.subjectBRCA1 Protein
dc.subjectBasic-Leucine Zipper Transcription Factors
dc.subjectDNA Helicases
dc.subjectFanconi Anemia Complementation Group Proteins
dc.subjectGerm-Line Mutation
dc.subjectHumans
dc.subjectLeucine Zippers
dc.subjectMutagenesis, Site-Directed
dc.subjectNuclear Proteins
dc.subjectTranscription Factors
dc.subjectAmino Acids, Peptides, and Proteins
dc.subjectCancer Biology
dc.subjectGenetic Phenomena
dc.subjectNeoplasms
dc.titleThe BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations
dc.typeJournal Article
dc.source.journaltitleProceedings of the National Academy of Sciences of the United States of America
dc.source.volume101
dc.source.issue8
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cancerbiology_pp/5
dc.identifier.contextkey679283
html.description.abstract<p>BACH1 is a nuclear protein that directly interacts with the highly conserved, C-terminal BRCT repeats of the tumor suppressor, BRCA1. Mutations within the BRCT repeats disrupt the interaction between BRCA1 and BACH1, lead to defects in DNA repair, and result in breast and ovarian cancer. BACH1 is necessary for efficient double-strand break repair in a manner that depends on its association with BRCA1. Moreover, some women with early-onset breast cancer and no abnormalities in either BRCA1 or BRCA2 carry germline BACH1 coding sequence changes, suggesting that abnormal BACH1 function contributes to tumor induction. Here, we show that BACH1 is both a DNA-dependent ATPase and a 5'-to-3' DNA helicase. In two patients with early-onset breast cancer who carry distinct germline BACH1 coding sequence changes, the resulting proteins are defective in helicase activity, indicating that these sequence changes disrupt protein function. These results reinforce the notion that mutant BACH1 participates in breast cancer development.</p>
dc.identifier.submissionpathcancerbiology_pp/5
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentDepartment of Cancer Biology
dc.source.pages2357-62


This item appears in the following Collection(s)

Show simple item record